Skip to main content

Modest Gain This Week for the BCW Index

The BCW Index rose .9 percent for the week ended Tuesday, outgaining the Nasdaq, which rose .2 percent for the tracking period, and the Nasdaq Biotech Index, which climbed .7 percent. The Dow Jones Industrial Average declined .3 percent.

Shares of Bruker BioSciences rose 4.3 percent to lead the Index, while Harvard Bioscience continued its recent ascent with a 4 percent gain for the week. Only four firms in the Index posted declines this week, led by a 1.7 percent dip for Bio-Rad Laboratories.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(Dec. 13, 2005)
Last Price
(Dec. 6, 2005)
% change
Agilent
A
35.98
34.94
2.98
Applied Biosystems
ABI
27.57
27.34
0.84
Beckman
BEC
57.22
55.73
2.67
Bio-Rad
BIO
60.14
61.19
-1.72
Bruker
BRKR
5.4
5.18
4.25
Fisher Scientific
FSH
64.52
63.34
1.86
GE
GE
35.47
35.8
-0.92
Harvard Bio
HBIO
4.69
4.51
3.99
Invitrogen
IVGN
66.56
65.6
1.46
Molecular Devices
MDCC
28.21
28.02
0.68
PerkinElmer
PKI
23.4
23.06
1.47
Qiagen
QGEN
11.67
11.36
2.73
Sigma
SIAL
65.2
65.41
-0.32
Stratagene
STGN
10.69
10.49
1.91
Thermo
TMO
30.76
31.25
-1.57
Waters
WAT
39.29
38.55
1.92
BCW Index Average
35.42
35.11
0.89
The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.